Managing pre-competitive collaboration in Life Sciences: Testimonials on outcomes & limits of European consortia.

Managing pre-competitive collaboration in Life Sciences: Testimonials on outcomes & limits of European consortia.

Which research topics are considered good candidates for competitive consortia at the time of precision medicine? Are the current collaborative models (IMI, H2020…) adapted to the research needs? How to balance each party’s interests and define the domain of precompetitive research. How can IP problematics be managed?

Kostas Skarvelakis

Innovation Business Development Director
France
Ayming

Karen Godbold

Senior Director, Global Public-Private Partnerships
United Kingdom
Pfizer

Lee Wen Hwa

CEO // Director– Affordable medicines Programme, Oxford Martin School
United Kingdom
ACTION AGAINST AMD // UNIVERSITY OF OXFORD
  • No products in the cart.